Phosphoinositide-3 Kinase Inhibitors

All categories
DBCAT005566Pharmacologic class

Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. A DrugBank category of 3 drugs. 2 of them are approved.

Drugs

What you can answer from here — as of January 13, 2022

3DrugsEach linked to its full drug card
Listed above
5Drug targetsEvery drug–target pair in the class, with bond type
Sign in
9Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Phosphoinositide-3 Kinase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In